Wirksame neue Medikamente gegen schwere Krankheiten wie Krebs oder CF sind überall in der EU zugelassen, aber nicht überall verfügbar: Warum die Pharmaindustrie arme gegen reiche Länder ausspielen kann und was Deutschland damit zu tun hat. #szplus #SZPlus sueddeutsche.de/projekte/artik…

Patients suffering from cancer or other serious diseases rarely realise that their fate can depend on secret price deals struck between state officials and pharma executives, Investigative Europe can reveal. buff.ly/3XolMC4

🔍 Take a look a this new collaborative investigation from out friends at Investigate Europe, which unveiled Europe's secret drug pricing system 👇

#Thread: Πανευρωπαϊκή έρευνα Investigate Europe, #ReportersUnited, Süddeutsche Zeitung, WDR, NDR.de και ΜΜΕ 20 χωρών. ❗Πώς η φαρμακοβιομηχανία κερδίζει στρέφοντας τη μία χώρα απέναντι στην άλλη. ✍️ Ευρυδίκη Μπερσή Lorenzo Buzzoni Maxence Peigné 🎨 Αλ. Μπαράκου #Deadlyprices investigate-europe.eu/posts/deadly-p…

#Deadlyprices our newly launched investigation into Europe's secret drug pricing system and unequal access to life-saving medicines is out in 20 countries, in collaboration with 25 media partners across Europe. Check it out! investigate-europe.eu/themes/investi…

Cada día resulta más difícil creer en ciertos tribunales: "La Audiencia Nacional avala la batalla de Sanidad para impedir que se conozca el precio real de los fármacos" Y sí, una vergüenza lo de Sanidad durante cinco años. Investigate Europe #Deadlyprices infolibre.es/politica/sanid…

La guerra dei farmaci. Il sistema segreto dei prezzi: accordi imposti da Big Pharma. I colossi del settore riescono a ottenere sconti differenti nei diversi Paesi europei. Così le nazioni più ricche pagano meno. L'inchiesta di Investigate Europe #deadlyprices ilfattoquotidiano.it/in-edicola/art…

#Deadlyprices, come si muore in Ue: senza rimborsi, negato l’accesso ai salva-vita. Le società scelgono gli stati più redditizi per lanciare i prodotti. L'inchiesta di Investigate Europe (di Lorenzo Buzzoni e Nico Schmidt) ilfattoquotidiano.it/in-edicola/art…

#Deadlyprices, studi clinici di Ema: così viene sacrificata la salute dei pazienti. Su pressione delle case farmaceutiche, che pagano l’ente regolatorio europeo, vengono commercializzati nuovi medicinali potenzialmente pericolosi. Investigate Europe ilfattoquotidiano.it/in-edicola/art…

Le aziende farmaceutiche scelgono di lanciare i propri farmaci nei Paesi con volumi di mercato maggiori e quindi più redditizi. investigate-europe.eu/it/posts/deadl…

🧵Tα λεφτά σου ή τη ζωή σου! Έρευνα Investigate Europe, #ReportersUnited & 19 ΜΜΕ. ❗Αποκάλυψη: Οι φαρμακευτικές (στα κρυφά) πωλούν φτηνά στους ισχυρούς & ακριβά στους αδύναμους λαούς της ΕΕ. ✍️ Ευρυδίκη Μπερσή Maxence Peigné Nico Schmidt Harald Schumann Lorenzo Buzzoni reportersunited.gr/13088/farmaka-…

📽️Un sentiment d'abandon politique a poussé l'Europe rurale à voter pour des partis d'extrême droite. "Une géographie du mécontentement", le 2e épisode d'une série de documentaires lancée par Investigate Europe et RTP1, est en accès libre sur notre site: bit.ly/4cPIeIw

‘While the rich and powerful devote their energy, resources and connections to the production of mass violence, civil society activists devote theirs to resisting it.’ - Anna Stavrianakis Get your copy: Monstrous Anger of the Guns 📚OUT NOW!📚 plutobooks.com/9780745350363/…

"This book, Monstrous Anger of the Guns, is the most important and timely book you'll see this year" - Jeremy Corbyn says that the arms industry should be reduced so that we can deal with the real social and environmental problems that the world faces: youtu.be/hkNKbkBfpYc?si…

🚨 REVEALED: Big Pharma millions flow to patient groups In a first Europe-wide investigation, we reveal how Pfizer, Novo Nordisk, Gilead and others gave €110m to patient organisations in 2022, raising concerns about industry influence over the sector. investigate-europe.eu/posts/deadly-p…

Patientenorganisationen sind wichtige Fürsprecher für kranke Menschen. Doch die Arbeit dieser oft einflussreichen Gruppen hängt häufig von Pharmafirmen ab. Wie sehr, zeigt eine europaweite Recherche von Investigate Europe sz.de/lux.GRbqZsiZ8H…

Così l’industria farmaceutica finanzia associazioni di malati. Nel 2022, 33 aziende hanno versato 110 mln a 3mila enti. Soldi usati per marketing e podcast (di Lorenzo Buzzoni, Chris Matthews e Manuel Rico) ilfattoquotidiano.it/in-edicola/art…

12 milioni all’Italia: autonomia a rischio e poca trasparenza. Il caso del medicinale Translarna. Gli enti vengono sentiti da Ema come esperti, dando la loro opinione sulla capacità di un farmaco. Lorenzo Buzzoni ilfattoquotidiano.it/in-edicola/art…

Investigación Las farmacéuticas destinan 110 millones al año a financiar a las asociaciones europeas de pacientes. Chris Matthews, Manuel Rico y Lorenzo Buzzoni en infoLibre Publicamos en exclusiva en España este trabajo de Investigate Europe ow.ly/EEbG50TnKAG

The pharmaceutical industry pours €110m into patient-advocacy organisations across the continent, new research by Investigate Europe reveals. Critics argue that funding threatens the independence of the sector — claims rejected by the groups. buff.ly/3TwCoES